For the quarter ending 2026-03-31, GLUE has $736,428K in assets. $214,512K in debts. $159,859K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 159,859 | 129,883 | 208,343 | 69,429 |
| Marketable securities | 506,361 | 247,221 | 182,915 | 221,165 |
| Collaboration receivable | 0 | 7,000 | - | - |
| Other receivables | 4,609 | 4,600 | 4,965 | 2,370 |
| Prepaid expenses and other current assets | 6,718 | 4,481 | 5,594 | 6,501 |
| Total current assets | 677,547 | 393,185 | 401,817 | 299,465 |
| Total property and equipment, at cost | 58,053 | 53,599 | 53,122 | - |
| Less accumulated depreciation | 29,644 | 27,613 | 25,524 | - |
| Property and equipment, net | 28,409 | 25,986 | 27,598 | 29,052 |
| Operating lease right-of-use assets | 24,693 | 24,386 | 25,065 | 25,674 |
| Restricted cash | 4,947 | 4,954 | 4,950 | 4,950 |
| Other long-term assets | 832 | 148 | 411 | 445 |
| Total assets | 736,428 | 448,659 | 459,841 | 359,586 |
| Accounts payable | 7,900 | 3,550 | 14,509 | 5,581 |
| Accrued expenses and other current liabilities | 25,594 | 26,694 | 17,902 | 13,767 |
| Current deferred revenue | 33,059 | 29,571 | 24,791 | 18,410 |
| Current portion of operating lease liability | 4,483 | 4,397 | 4,241 | 4,094 |
| Total current liabilities | 71,036 | 64,212 | 61,443 | 41,852 |
| Deferred revenue, net of current | 103,635 | 111,332 | 111,894 | 8,059 |
| Defined benefit plan liability | 5,260 | 5,265 | 4,740 | 4,558 |
| Operating lease liability, net of current | 34,581 | 34,794 | 35,927 | 37,037 |
| Total liabilities | 214,512 | 215,603 | 214,004 | 91,506 |
| Common stock, 0.0001 par value 500,000,000 shares authorized, 84,321,705 and 65,543,723 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 8 | 7 | 6 | 6 |
| Additional paid-in capital | 1,048,371 | 714,090 | 680,157 | 675,445 |
| Accumulated other comprehensive loss | -4,746 | -3,827 | -3,247 | -3,373 |
| Accumulated deficit | -521,717 | -477,214 | -431,079 | -403,998 |
| Total stockholders' equity | 521,916 | 233,056 | 245,837 | 268,080 |
| Total liabilities and stockholders' equity | 736,428 | 448,659 | 459,841 | 359,586 |
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)